Balance Sheet for Lexaria Bioscience Corp. (LXRP)

$ 0.2498   0.0074 (+3.05%) Volume: 44.76k 3:48 PM EDT Jul 15, 2020
Statement: View:
Assets [+] in Thousands of Dollars
08/2019 08/2018 08/2017 08/2016 08/2015
Cash and Equivalents 1,285 1,727 2,533 93 260
Restrictable Cash - - - - -
Marketable Securities 64 10 - - -
Accounts Receivable 112 205 2 - 31
Loans Receivable - - - - -
Other Receivables 161 61 44 28 31
Receivables 273 266 45 131 31
Inventories, Raw Materials 45 29 14 27 48
Inventories, Work in Progress - 10 11 13 48
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 82 48 42 94 120
Inventories, Other 127 87 67 135 187
Inventories, Adjustments & Allowances - - - - -
Inventories 127 87 67 135 168
Prepaid Expenses 69 194 150 151 215
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 1,819 2,284 2,795 510 675
Land and Improvements - - - - -
Buildings and Improvement 260 - - - -
Machinery, Furniture and Equipment 389 3 2 2 -
Construction in Progress 3 - - - -
Fixed Assets, Other (3) - - - -
Fixed Assets, Total 649 3 2 2 -
Gross Fixed Assets 649 3 2 2 -
Accumulated Depreciation (58) (2) - - -
Net Fixed Assets 591 1 2 2 -
Intangibles 265 147 63 54 37
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets - - - - -
Total Non-Current Assets 856 148 65 56 37
Total Assets 2,675 2,432 2,860 567 712
Liabilities [+] in Thousands of Dollars
08/2019 08/2018 08/2017 08/2016 08/2015
Accounts Payable (169) 42 75 421 55
Short Term Debt - - - - -
Notes Payable - - - - -
Accrued Expenses 290 - - - -
Accrued Liabilities 290 - - - -
Deferred Revenues 44 - 17 12 -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 19 2 - - -
Total Current Liabilities 185 44 92 434 55
Long Term Debt N/A N/A 135 45 N/A
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - (135) - -
Minority Interest 108 - (238) (178) (116)
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 108 - (238) (133) (116)
Total Liabilities 292 44 (146) 301 (61)
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 2,383 2,388 3,006 266 772
Common Par 79 76 68 51 44
Additional Paid in Capital 26,172 22,096 16,108 11,515 10,814
Cumulative Translation Adjustments - - - - -
Retained Earnings (23,868) (19,769) (13,170) (11,301) (10,086)
Treasury Stock - - - - -
Other Equity Adjustments - (14) - - -
Total Capitalization 2,383 2,388 3,141 311 772
Total Equity 2,383 2,388 3,006 266 772
Total Liabilities & Shareholder's Equity 2,675 2,432 2,860 567 712
Cash Flow (4,219) (6,611) (1,931) (1,278) (1,934)
Working Capital 1,634 2,240 2,703 76 620
Free Cash Flow (3,775) (2,603) (1,556) (681) (1,538)
Invested Capital 2,383 2,388 3,006 311 772
Shares Outstanding - Common Class Only 78,787 75,533 67,976 51,288 43,838
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 78,787 75,533 67,976 51,288 43,838
Total Common Shares Outstanding 78,787 75,533 67,976 51,288 43,838
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 77,792 70,960 58,766 43,840 39,701
Diluted Weighted Shares Outstanding 77,792 70,960 58,766 43,840 39,701